Skip to main content
VCbacked
Log inGet Started

Notch Therapeutics

Toronto, Canada

Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.

$15.5M raised
Jun 2024
Venture - Series Unknown
BiotechnologyDeveloper PlatformHealth Care

Top Investors

Samsara BioCapitalLumira VenturesCreative Destruction LabCasdin CapitalEcoR1 Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Notch Therapeutics

How much funding has Notch Therapeutics raised?
Notch Therapeutics has raised $15.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
Who are Notch Therapeutics's investors?
Notch Therapeutics's investors include Samsara BioCapital, Lumira Ventures, Creative Destruction Lab, Casdin Capital, EcoR1 Capital.
Where is Notch Therapeutics headquartered?
Notch Therapeutics is headquartered in Toronto, Canada.
What does Notch Therapeutics do?
Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
What stage is Notch Therapeutics at?
Notch Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Notch Therapeutics — Funding & Investors." VCBacked, June 14, 2024, https://www.vcbacked.co/company/notch-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2024). Notch Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/notch-therapeutics
Wikipedia (cite web)
{{cite web |title=Notch Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/notch-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K